NASDAQ:TGTX

Tg Therapeutics Stock Insider Trading

etoro logo Buy TGTX
*Your capital is at risk
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026

TG Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 37.24. In total, the insiders bought 8.13M and sold 5.58M TGTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
37.24
Buy 8.13M shares
Sell 5.58M shares
57% Buy Activity
Moderate Positive Correlation
Sell Signal Low Confidence
May 26, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 37.24.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 29, 2026
Sell
Common Stock
G-Gift
Charney Laurence N
Director
Director 13 197
Value: $0
Jan 28, 2026
Sell
Common Stock
G-Gift
Charney Laurence N
Director
Director 30 000
Value: $0
Jan 08, 2026
Buy
Common Stock
A-Award
Power Sean A
CFO
C-Suite Officer 90 000
Value: $2.75M
Jan 08, 2026
Buy
Common Stock
A-Award
Weiss Michael S
CEO
CEO / President 622 000
Value: $19.0M
Nov 24, 2025
Sell
Common Stock
S-Sale
Echelard Yann
Director
Director 5 000
Value: $162.9K
Nov 05, 2025
Sell
Common Stock
G-Gift
Weiss Michael S
CEO
CEO / President 803 717
Value: $0
Nov 05, 2025
Sell
Common Stock
G-Gift
Weiss Michael S
CEO
CEO / President 3 865 126
Value: $0
Sep 11, 2025
Sell
Common Stock
S-Sale
Lonial Sagar
Director
Director 20 852
Value: $672.3K
Sep 11, 2025
Sell
Common Stock
S-Sale
Lonial Sagar
Director
Director 20 852
Value: $672.3K
Jun 13, 2025
Sell
Common Stock
S-Sale
Echelard Yann
Director
Director 10 000
Value: $369.4K
Jun 13, 2025
Sell
Common Stock
S-Sale
Echelard Yann
Director
Director 10 000
Value: $369.4K
Jun 12, 2025
Buy
Common Stock
A-Award
Echelard Yann
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Charney Laurence N
Director
Director 21 408
Value: $800.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Hoberman Kenneth
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Hume Daniel
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Lonial Sagar
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Lonial Sagar
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Hume Daniel
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Hoberman Kenneth
Director
Director 14 718
Value: $550.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Charney Laurence N
Director
Director 21 408
Value: $800.0K
Jun 12, 2025
Buy
Common Stock
A-Award
Echelard Yann
Director
Director 14 718
Value: $550.0K
Mar 17, 2025
Sell
Common Stock
G-Gift
Hume Daniel
Director
Director 62 459
Value: $0
Mar 17, 2025
Sell
Common Stock
G-Gift
Hume Daniel
Director
Director 62 459
Value: $0
Mar 10, 2025
Sell
Common Stock
G-Gift
Charney Laurence N
Director
Director 6 000
Value: $0
Mar 10, 2025
Sell
Common Stock
G-Gift
Charney Laurence N
Director
Director 6 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT TG THERAPEUTICS
TG Therapeutics
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE